IBDEI0GV ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8157,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,8158,0)
 ;;=364.23^^52^578^81
 ;;^UTILITY(U,$J,358.3,8158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8158,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,8158,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,8158,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,8159,0)
 ;;=364.51^^52^578^8
 ;;^UTILITY(U,$J,358.3,8159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8159,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,8159,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,8159,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,8160,0)
 ;;=364.53^^52^578^100
 ;;^UTILITY(U,$J,358.3,8160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8160,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,8160,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,8160,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,8161,0)
 ;;=364.57^^52^578^33
 ;;^UTILITY(U,$J,358.3,8161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8161,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,8161,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,8161,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,8162,0)
 ;;=364.60^^52^578^26
 ;;^UTILITY(U,$J,358.3,8162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8162,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,8162,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,8162,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,8163,0)
 ;;=364.73^^52^578^97
 ;;^UTILITY(U,$J,358.3,8163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8163,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,8163,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,8163,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,8164,0)
 ;;=364.75^^52^578^107
 ;;^UTILITY(U,$J,358.3,8164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8164,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,8164,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,8164,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,8165,0)
 ;;=364.76^^52^578^58
 ;;^UTILITY(U,$J,358.3,8165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8165,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,8165,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,8165,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,8166,0)
 ;;=364.77^^52^578^3
 ;;^UTILITY(U,$J,358.3,8166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8166,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,8166,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,8166,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,8167,0)
 ;;=364.89^^52^578^62
 ;;^UTILITY(U,$J,358.3,8167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8167,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,8167,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,8167,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,8168,0)
 ;;=364.9^^52^578^61
 ;;^UTILITY(U,$J,358.3,8168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8168,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,8168,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,8168,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,8169,0)
 ;;=370.00^^52^578^25
 ;;^UTILITY(U,$J,358.3,8169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8169,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,8169,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,8169,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,8170,0)
 ;;=370.20^^52^578^66
 ;;^UTILITY(U,$J,358.3,8170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8170,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,8170,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,8170,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,8171,0)
 ;;=370.31^^52^578^99
 ;;^UTILITY(U,$J,358.3,8171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8171,1,3,0)
 ;;=3^Phlyctenule Keratoconj
